Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism. 1978

A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro

1. The 24 h urinary excretion of kallikrein has been studied in 40 normotensive control subjects and in 74 age-matched patients with essential hypertension under similar conditions. By use of the renin-sodium index, hypertensive patients were divided into two subgroup: low-renin hypertension and normal-renin hypertension patients. Urinary kallikrein determinations were also obtained from six hypertensive patients with primary aldosteronism. 2. Urinary kallikrein was significantly lower both in patients with normal-renin and low-renin essential hypertension. Urinary kallikrein excretion was very high in the patients with primary aldosteronism. 3. In nine hypertensive patients beta-adreno-receptor-blocking therapy caused a significant decrease of plasma renin activity, but had no significant effect on urinary kallikrein excretion. 4. The results support the concept that low urinary kallikrein is likely to be a marker of essential hypertension. Under certain conditions its excretion is positively related to mineralocorticoid hormone concentrations but it is not primarily related to the renin-angiotensin system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
October 1974, Klinische Wochenschrift,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
February 1977, The Tohoku journal of experimental medicine,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
April 1979, The Journal of clinical endocrinology and metabolism,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
June 1983, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
December 1983, Transplantation proceedings,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
February 1969, Archives of internal medicine,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
December 1978, Agents and actions,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
November 1977, Circulation,
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
March 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A Lechi, and G Covi, and C Lechi, and A Corgnati, and E Arosio, and M Zatti, and L A Scuro
May 1979, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!